Modern Therapeutic Approaches Against Pseudomonas aeruginosa Infections

被引:4
作者
Dorotkiewicz-Jach, Agata [1 ]
Augustyniak, Daria [1 ]
Olszak, Tomasz [1 ]
Drulis-Kawa, Zuzanna [1 ]
机构
[1] Univ Wroclaw, Inst Genet & Microbiol, PL-51148 Wroclaw, Poland
关键词
Alternative therapies; modern therapies; Pseudomonas aeruginosa; resistance; QUORUM-SENSING INHIBITORS; GRAM-NEGATIVE ORGANISMS; EFFLUX PUMP INHIBITORS; IN-VITRO ACTIVITY; PHOTODYNAMIC ANTIMICROBIAL CHEMOTHERAPY; HOMOSERINE LACTONE ACYLASE; BETA-LACTAMASE INHIBITOR; BACTERIOPHAGE THERAPY; CYSTIC-FIBROSIS; PHAGE THERAPY;
D O I
暂无
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Despite the enormous progress that has been made in the last few decades in the field of drug design as well as virulence of pathogenic bacteria, the gradual spread of drug resistance can be observed. Only two new classes of antibiotics have been brought to medicine in the last 30 years. The need for novel antibacterial drugs is especially pressing when considering infections caused by multidrug-resistant (MDR) pathogens such as Pseudomonas aeruginosa. The discovery and development of new anti-pseudomonal therapies is one of the main challenges of modern pharmaceutical sciences. The great variety of innovative approaches presented in the current literature is astonishing. In this review, modern, promising strategies against P. aeruginosa infections are described. Antimicrobials, including new antibiotics, beta-lactamase and efflux pump inhibitors, quorum quenching molecules and nanoparticles with antibacterial activity are currently being intensively studied. Methods of prevention of infection through vaccines, therapeutic antibodies and development of antimicrobial peptides are discussed as approaches that support the human immunological system. Finally, development of alternative/supportive therapies such as phage therapy and photodynamic therapy, in which the mechanism of action is completely different from current antibiotic therapy, is of great importance.
引用
收藏
页码:1642 / 1664
页数:23
相关论文
共 211 条
[1]   Gentamicin-loaded nanoparticles show improved antimicrobial effects towards Pseudomonas aeruginosa infection [J].
Abdelghany, Sharif M. ;
Quinn, Derek J. ;
Ingram, Rebecca J. ;
Gilmore, Brendan F. ;
Donnelly, Ryan F. ;
Taggart, Clifford C. ;
Scott, Christopher J. .
INTERNATIONAL JOURNAL OF NANOMEDICINE, 2012, 7 :4053-4063
[2]  
Afacan NJ, 2012, CURR PHARM DESIGN, V18, P807, DOI 10.2174/138161212799277617
[3]   Bacteriophages φMR299-2 and φNH-4 Can Eliminate Pseudomonas aeruginosa in the Murine Lung and on Cystic Fibrosis Lung Airway Cells [J].
Alemayehu, Debebe ;
Casey, Pat G. ;
McAuliffe, Olivia ;
Guinane, Caitriona M. ;
Martin, James G. ;
Shanahan, Fergus ;
Coffey, Aidan ;
Ross, R. Paul ;
Hill, Colin .
MBIO, 2012, 3 (02)
[4]   Efficacy and Safety of Liposomal Clarithromycin and Its Effect on Pseudomonas aeruginosa Virulence Factors [J].
Alhajlan, Mai ;
Alhariri, Moayad ;
Omri, Abdelwahab .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2013, 57 (06) :2694-2704
[5]   Efficacy of Liposomal Bismuth-Ethanedithiol-Loaded Tobramycin after Intratracheal Administration in Rats with Pulmonary Pseudomonas aeruginosa Infection [J].
Alhariri, Moayad ;
Omri, Abdelwahab .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2013, 57 (01) :569-578
[6]   Computational discovery of putative quorum sensing inhibitors against LasR and RhlR receptor proteins of Pseudomonas aeruginosa [J].
Annapoorani, Angusamy ;
Umamageswaran, Venugopal ;
Parameswari, Radhakrishnan ;
Pandian, Shunmugiah Karutha ;
Ravi, Arumugam Veera .
JOURNAL OF COMPUTER-AIDED MOLECULAR DESIGN, 2012, 26 (09) :1067-1077
[7]  
[Anonymous], 50 INT C ANT AG CHEM
[8]   Direct and Indirect Antimicrobial Activities of Neuropeptides and their Therapeutic Potential [J].
Augustyniak, Daria ;
Nowak, Judyta ;
Lundy, Fionnuala T. .
CURRENT PROTEIN & PEPTIDE SCIENCE, 2012, 13 (08) :723-738
[9]   New antibiotics for bad bugs: where are we? [J].
Bassetti, Matteo ;
Merelli, Maria ;
Temperoni, Chiara ;
Astilean, Augusta .
ANNALS OF CLINICAL MICROBIOLOGY AND ANTIMICROBIALS, 2013, 12
[10]   Type IIA topoisomerase inhibition by a new class of antibacterial agents [J].
Bax, Benjamin D. ;
Chan, Pan F. ;
Eggleston, Drake S. ;
Fosberry, Andrew ;
Gentry, Daniel R. ;
Gorrec, Fabrice ;
Giordano, Ilaria ;
Hann, Michael M. ;
Hennessy, Alan ;
Hibbs, Martin ;
Huang, Jianzhong ;
Jones, Emma ;
Jones, Jo ;
Brown, Kristin Koretke ;
Lewis, Ceri J. ;
May, Earl W. ;
Saunders, Martin R. ;
Singh, Onkar ;
Spitzfaden, Claus E. ;
Shen, Carol ;
Shillings, Anthony ;
Theobald, Andrew J. ;
Wohlkonig, Alexandre ;
Pearson, Neil D. ;
Gwynn, Michael N. .
NATURE, 2010, 466 (7309) :935-U51